Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prucalopride Versus Placebo in Gastroparesis
NCT02031081Phase 3Completed
- Sponsor
- University of Calgary
- Start
- Mar 2014
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of prucalopride in gastroparesis (2 arms), sponsored by University of Calgary. Primary endpoint: Change In Cumulative Meal-related Symptoms at Day 28. Started Mar 2014; status: completed.
02
Drugs
prucalopride
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT02031081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02031081.